» Articles » PMID: 37537779

Microvascular Function and Inflammatory Activation in Takotsubo Cardiomyopathy

Overview
Journal ESC Heart Fail
Date 2023 Aug 4
PMID 37537779
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The aim of this study was to determine microvascular function in the acute phase of Takotsubo syndrome (TTS) and to identify inflammatory mediators that could reflect TTS-induced pathology.

Methods And Results: The study included 20 females [median age 65 years; interquarile range (IQR) = 58-70 years] with TTS according to the Mayo diagnostic criteria. During heart catheterization, we determined the index of microvascular resistance (IMR) and drew blood samples almost simultaneously from the aorta and coronary sinus. Cardiac magnetic resonance imaging (MRI) was done in the acute phase. We present descriptive coronary physiology and cardiac MRI data and compare inflammatory biomarkers between samples from the aorta, coronary sinus, and venous samples after 3 months using the Wilcoxon signed-rank test. For comparison, we also analysed the actual biomarkers in venous blood from 15 healthy female controls. A supplementary analysis explored Spearman's rank correlation between the inflammatory biomarkers, IMR, MRI data, and cardiac biomarkers. The median IMR was 16.5 mmHg·s (IQR = 10.5-28.2 mmHg·s), which was only slightly higher than that in the reference populations. Seven (35%) of the study subjects had IMR > 25 mmHg·s, suggesting a microvascular dysfunction. IMR was not affected by time from symptom onset. According to MRI, the apical region of the left ventricle was affected in 65% of the subjects. The median ejection fraction was 41% (IQR = 31-48%). Biomarker analyses revealed elevation of markers for extracellular matrix remodelling and fibrosis, inflammation, immune activation, and upstream inflammation as compared with healthy controls. Only the levels of interleukin (IL)-1 receptor antagonist and soluble T-cell immunoglobulin mucin domain-3 (sTIM-3) were higher in the coronary sinus than in the aorta. No variable was significantly correlated with IMR. The IL-6 level in the aorta was inversely correlated with the left ventricular ejection fraction. Growth differentiation factor-15, osteoprotegerin, and von Willebrand factor levels in both aorta and coronary sinus were positively correlated with N-terminal-pro-brain-natriuretic peptide, while the correlations of IL-6 and sTIM-3 with N-terminal-pro-brain-natriuretic peptide were restricted to the aorta and coronary sinus, respectively. While most of the markers were within normal limits after 3 months, matrix metalloproteinase-9 increased during follow-up to reach levels higher than those in the healthy controls.

Conclusion: The median IMR was only slightly elevated in this study, but about one-third of the patients had values indicating microvascular dysfunction. The present study supports the involvement of several inflammatory pathways in TTS, including monocyte/macrophage activation, with sTIM-3 as a potential novel marker.

Citing Articles

Impact of Coronary Microvascular Dysfunction in Takotsubo Syndrome: Cause, Consequence or Both?.

Caglioni S, Mele D, Milzi A, Bergamaschi L, Pavon A, Landi A Rev Cardiovasc Med. 2024; 25(5):163.

PMID: 39076465 PMC: 11267194. DOI: 10.31083/j.rcm2505163.


Is index of microvascular resistance of Sisyphean utility in Takotsubo syndrome?.

Lim P ESC Heart Fail. 2024; 11(6):4438-4440.

PMID: 39005002 PMC: 11631245. DOI: 10.1002/ehf2.14943.


The role of inflammation in takotsubo syndrome: A new therapeutic target?.

Li X, Yang J, Xu D J Cell Mol Med. 2024; 28(12):e18503.

PMID: 38896112 PMC: 11186299. DOI: 10.1111/jcmm.18503.


2024 update in heart failure.

Beghini A, Sammartino A, Papp Z, von Haehling S, Biegus J, Ponikowski P ESC Heart Fail. 2024; 12(1):8-42.

PMID: 38806171 PMC: 11769673. DOI: 10.1002/ehf2.14857.


Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg?.

Celeski M, Nusca A, de Luca V, Antonelli G, Cammalleri V, Melfi R J Cardiovasc Dev Dis. 2024; 11(2).

PMID: 38392253 PMC: 10889783. DOI: 10.3390/jcdd11020039.


References
1.
Wang J, Li C, Fu J, Wang X, Feng X, Pan X . Tim-3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B. Scand J Immunol. 2019; 89(5):e12755. DOI: 10.1111/sji.12755. View

2.
Gullestad L, Ueland T, Kjekshus J, Nymo S, Hulthe J, Muntendam P . Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Eur Heart J. 2012; 33(18):2290-6. DOI: 10.1093/eurheartj/ehs077. View

3.
Daniels D, Fearon W . The index of microcirculatory resistance (IMR) in takotsubo cardiomyopathy. Catheter Cardiovasc Interv. 2010; 77(1):128-31. DOI: 10.1002/ccd.22599. View

4.
Erkol A, Oduncu V, Pala S, Kizilirmak F, Kilicgedik A, Yilmaz F . Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. Atherosclerosis. 2012; 221(1):254-9. DOI: 10.1016/j.atherosclerosis.2011.12.031. View

5.
Solberg O, Stavem K, Ragnarsson A, Beitnes J, Skardal R, Seljeflot I . Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study. Catheter Cardiovasc Interv. 2019; 94(5):660-668. DOI: 10.1002/ccd.28157. View